Acumen Pharmaceuticals, Inc.
corporate_fare Company Profile
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 23 items for ABOS at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Acumen Pharma Secures $35.75M in Private Placement at 17.5% Discount, Funds EBD Program
- Acumen Secures $35.75M Private Placement, Reveals Strong Preclinical Data for Alzheimer's EBD Program
- Acumen Pharmaceuticals Highlights Strong Sabirnetug Phase 1 Data and EBD Program Advancement in Updated Presentation
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$121.33M
Diluted EPS
-$2.00
Op. Cash Flow
-$115.54M
Free Cash Flow
-$115.63M
Operating Income
-$123.83M
Cash & Equivalents
$53.99M
Total Debt
$31.16M
Debt / Equity
0.44×
Shares Outstanding
60.58M sh
Source: 10-K · filed 2026-03-26 · accession 0001628280-26-021413
show_chartPrice Chart
Loading chart...
feed ABOS - Filings & News (Page 2)
ABOS
Mar 16, 2026, 7:01 AM EDT
Price at Filing:
$4.00
Real-time Price:
$0.1757
Change:
-$3.82 (-96%)
Market Cap:
$13.489M
ABOS
Mar 16, 2026, 6:30 AM EDT
Price at Filing:
$3.60
Real-time Price:
$0.1757
Change:
-$3.42 (-95%)
Market Cap:
$13.489M
ABOS
Jan 12, 2026, 8:33 AM EST
Price at Filing:
$1.76
Real-time Price:
$0.1757
Change:
-$1.58 (-90%)
Market Cap:
$13.489M